本文刊登于《中國實(shí)用婦科與產(chǎn)科雜志》2021,37(5):558-563
DOI:10.19538/j.fk2021050114
【引用本文】“高齡產(chǎn)婦妊娠期并發(fā)癥防治策略研究”項(xiàng)目專家組.高齡婦女瘢痕子宮再妊娠管理專家共識(shí)(2021年版)[J].中國實(shí)用婦科與產(chǎn)科雜志,2021,37(5):558-563.
作者:“高齡產(chǎn)婦妊娠期并發(fā)癥防治策略研究”項(xiàng)目專家組
基金項(xiàng)目:國家重點(diǎn)研發(fā)計(jì)劃(2016YFC1000404);國家自然科學(xué)基金面上項(xiàng)目(81370735,81771610);盛京自由研究者基金(201706);遼寧省特聘教授(2017);沈陽市科技計(jì)劃項(xiàng)目(20-205-4-004)
通訊作者:喬寵,中國醫(yī)科大學(xué)附屬盛婦產(chǎn)科,遼寧 沈陽 110004,電子信箱:qiaochong2002@163.com
執(zhí)筆專家:喬寵(中國醫(yī)科大學(xué)附屬盛);劉彩霞(中國醫(yī)科大學(xué)附屬盛);趙揚(yáng)玉(北京大學(xué)第三醫(yī)院)
參與共識(shí)討論專家:王妍(北京大學(xué)第三醫(yī)院);趙揚(yáng)玉(北京大學(xué)第三醫(yī)院);漆洪波(重慶醫(yī)科大學(xué)附屬第一醫(yī)院);顧蔚蓉(復(fù)旦大學(xué)附屬婦產(chǎn)科醫(yī)院);李宏田(北京大學(xué)公共衛(wèi)生學(xué)院);魏瑗(北京大學(xué)第三醫(yī)院);魏軍(中國醫(yī)科大學(xué)附屬盛);王雁玲(中國科學(xué)院動(dòng)物研究所);劉興會(huì)(四川大學(xué)華西第二醫(yī)院);李笑天(復(fù)旦大學(xué)附屬婦產(chǎn)科醫(yī)院);楊慧霞(北京大學(xué)第一醫(yī)院);陳敦金(廣州醫(yī)科大學(xué)附屬第三醫(yī)院);劉建蒙(北京大學(xué)公共衛(wèi)生學(xué)院);魏玉梅(北京大學(xué)第一醫(yī)院);劉彩霞(中國醫(yī)科大學(xué)附屬盛);喬寵(中國醫(yī)科大學(xué)附屬盛)
秘書:張立陽(中國醫(yī)科大學(xué)附屬盛);陳炳南(中國醫(yī)科大學(xué)附屬盛);熊子越(中國醫(yī)科大學(xué)附屬盛)
1 孕前評(píng)估和備孕指導(dǎo)
[推薦及共識(shí)]
[解讀]
問題2 瘢痕子宮女性的最佳妊娠間隔是多久?
2 孕早期篩查與管理
[推薦及共識(shí)]
[解讀]
3 孕中晚期管理
問題6 如何預(yù)測(cè)瘢痕子宮妊娠可能出現(xiàn)的風(fēng)險(xiǎn)?
4 終止妊娠與分娩期管理
5 產(chǎn)褥期管理
[1] 中華醫(yī)學(xué)會(huì)婦產(chǎn)科學(xué)分會(huì)妊娠期高血壓疾病學(xué)組.高齡婦女妊娠前、妊娠期及分娩期管理專家共識(shí)(2019)[J].中華婦產(chǎn)科雜志,2019,54(1):24-26.
[2] 洪燕語,賀晶.子宮瘢痕憩室對(duì)再生育的影響[J].中華圍產(chǎn)醫(yī)學(xué)雜志,2016,19(9):684-687.
[3] 中華醫(yī)學(xué)會(huì)計(jì)劃生育學(xué)分會(huì).剖宮產(chǎn)術(shù)后子宮瘢痕憩室診治專家共識(shí)[J].中華婦產(chǎn)科雜志,2019,54(3):145-148.
[4] 上海市母嬰安全專家委員會(huì),上海市醫(yī)學(xué)會(huì)圍產(chǎn)醫(yī)學(xué)??品謺?huì),上海市醫(yī)學(xué)會(huì)婦產(chǎn)科??品謺?huì)產(chǎn)科學(xué)組,等.上海市產(chǎn)科靜脈血栓栓塞癥防治的專家共識(shí)[J].上海醫(yī)學(xué),2020,43(11):645-650.
[5] 陳倩,胡雅毅.妊娠相關(guān)靜脈血栓栓塞的危險(xiǎn)因素及其預(yù)防決策[J].中華婦幼臨床醫(yī)學(xué)雜志(電子版),2019,15(6):623-631.
[6] Gabbay-Benziv R. Reducing the risk of venous thromboembolism during pregnancy and the puerperium[J].Harefuah,2019,158(1):53-59.
[7] Gonzalez N,Tulandi T.Cesarean scar pregnancy:a systematic review[J].J Minim Invasive Gynecol,2017,24(5):731-738.
[8] Bujold E,Gauthier RJ.Risk of uterine rupture associated with an interdelivery interval between 18 and 24 months[J].Obstet Gynecol,2010,115(5):1003-1006.
[9] Schummers L,Hutcheon JA,Diaz SH,et al.Association of short interpregnancy interval with pregnancy outcomes according to maternal age[J].JAMA Intern Med,2018,178(12):1661-1670.
[10] Milazzo GN,Catalano A,Badia V,et al.Myoma and myomectomy:poor evidence concern in pregnancy[J].J Obstet Gynaecol Res,2017,43(12):1789-1804.
[11] 冷金花,史精華.子宮腺肌病合并不孕治療策略[J].中國實(shí)用婦科與產(chǎn)科雜志,2020,36(6):516-519.
[12] 子宮肌瘤的診治中國專家共識(shí)專家組.子宮肌瘤的診治中國專家共識(shí)[J].中華婦產(chǎn)科雜志,2017,52(12):793-800.
[13] 楊靜,王素敏.宮腔鏡下子宮縱隔切開術(shù)后妊娠結(jié)局分析[J].江蘇醫(yī)藥,2019,45(2):164-166.
[14] 中華醫(yī)學(xué)會(huì)婦產(chǎn)科學(xué)分會(huì)計(jì)劃生育學(xué)組.剖宮產(chǎn)術(shù)后子宮瘢痕妊娠診治專家共識(shí)(2016)[J].中華婦產(chǎn)科雜志,2016,51(8):568-572.
[15] 黃志宏,潘微,吳桂萍,等.胎兒先天性心臟病的高危因素及產(chǎn)前超聲診斷[J].中國全科醫(yī)學(xué),2004,7(18):1310-1311.
[16] 張志濤,尹少尉,劉彩霞,等.射頻消融選擇性減胎術(shù)技術(shù)規(guī)范(2021年更新版)[J].中國實(shí)用婦科與產(chǎn)科雜志,2021,37(2):181-184.
[17] 張雪松,侯成禎,顧向應(yīng).中期妊娠-剖宮產(chǎn)瘢痕妊娠診治進(jìn)展[J].中國實(shí)用婦科與產(chǎn)科雜志,2018,34(3):344-348.
[18] Getahun D,Oyelese Y,Salihu HM,et al.Previous cesarean delivery and risks of placenta previa and placental abruption[J].Obstet Gynecol,2006,107(4):771-778.
[19] 張藝珊,顧向應(yīng).瘢痕子宮再次妊娠的全程管理[J].中國計(jì)劃生育和婦產(chǎn)科,2019,11(5):5-8.
[20] Jauniaux E,Campos DAD,Management FPAD.FIGO consensus guidelines on placenta accreta spectrum disorders:introduction[J].Int J Gynaecol Obstet,2018,140(3):261-264.
[21] 中華醫(yī)學(xué)會(huì)圍產(chǎn)醫(yī)學(xué)分會(huì),中華醫(yī)學(xué)會(huì)婦產(chǎn)科學(xué)分會(huì)產(chǎn)科學(xué)組.胎盤植入診治指南(2015)[J].中華產(chǎn)科急救電子雜志,2016,5(1):26-31.
[22] Collins SL,Ashcroft A,Braun T,et al.Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP)[J].Ultrasound Obstet Gynecol,2016,47(3):271-275.
[23] 廖姍姍,栗娜,劉彩霞,等.三維能量多普勒超聲產(chǎn)前診斷兇險(xiǎn)性前置胎盤合并胎盤植入價(jià)值研究[J].中國實(shí)用婦科與產(chǎn)科雜志,2017,33(12):1262-1266.
[24] 種軼文,張愛青,王妍,等.超聲評(píng)分系統(tǒng)預(yù)測(cè)胎盤植入兇險(xiǎn)程度的價(jià)值[J].中華圍產(chǎn)醫(yī)學(xué)雜志,2016,19(9):705-709.
[25] 陳練,陳明,裴新龍,等.基于MRI征象的評(píng)分模型預(yù)測(cè)侵襲性胎盤植入和不良臨床結(jié)局的價(jià)值[J].中華圍產(chǎn)醫(yī)學(xué)雜志,2021,24(1):32-39.
[26] 李萍,翟俊英,李宛玲.血清HCG、AFP水平聯(lián)合MRI在前置胎盤植入及其分類診斷中的應(yīng)用[J].中國CT和MRI雜志,2019,17(2):84-86.
[27] 李林源,武海英,王秋明,等.經(jīng)陰道三維超聲微泡造影與增強(qiáng)磁共振對(duì)胎盤前置狀態(tài)中孕引產(chǎn)患者胎盤植入診斷價(jià)值研究[J].中國實(shí)用婦科與產(chǎn)科雜志,2021,37(2):237-240.
[28] Tanos V,Toney ZA.Uterine scar rupture-prediction,prevention,diagnosis,and management[J].Best Pract Res Clin Obstet Gynaecol,2019,59:115-131.
[29] Ash A,Smith A,Maxwell D.Caesarean scar pregnancy[J].BJOG,2007,114(3):253-263.
[30] Martel MJ,MacKinnon CJ.No.155-Guidelines for vaginal birth after previous caesarean birth[J].J Obstet Gynaecol Can,2018,40(3):e195-e207.
[31] Dy J,DeMeester S,Lipworth H,et al.No.382-Trial of labour after caesarean[J].J Obstet Gynaecol Can,2019,41(7):992-1011.
[32] ACOG.ACOG Practice Bulletin No.205:vaginal birth after cesarean delivery[J].Obstet Gynecol,2019,133(2):e110-e127.
[33] Seow KM,Huang LW,Lin YH,et al.Cesarean scar pregnancy:issues in management[J].Ultrasound Obstet Gynecol,2004,23(3):247-253.
[34] Zhang L,Li H,Li J,et al.Prediction of iatrogenic preterm birth in patients with scarred uterus:a retrospective cohort study in Northeast China[J].BMC Pregnancy Childbirth,2020,20(1):490.
[35] Frank ZC,Lee VR,Hersh AR,et al.Timing of delivery in women with prior uterine rupture:a decision analysis[J].J Matern Fetal Neonatal Med,2021,34(2):238-244.
[36] Ma'ayeh M,Haight P,Oliver EA,et al.Timing of repeat cesarean delivery for women with a prior classical incision[J].Am J Perinatol,2020.DOI:10.1055/s-0040-1718576.
[37] Chiossi G,Lai Y,Landon MB,et al.Timing of delivery and adverse outcomes in term singleton repeat cesarean deliveries[J].Obstet Gynecol,2013,121(3):561-569.
[38] 趙揚(yáng)玉,王妍,陳練.胎盤植入的圍手術(shù)期管理[J].中華婦產(chǎn)科雜志,2018,53(11):787-789.
[39] Silver RM,Barbour KD.Placenta accreta spectrum:accreta,increta,and percreta[J].Obstet Gynecol Clin North Am,2015,42(2):381-402.
[40] 中華醫(yī)學(xué)會(huì)婦產(chǎn)科學(xué)分會(huì)產(chǎn)科學(xué)組.剖宮產(chǎn)術(shù)后再次妊娠陰道分娩管理的專家共識(shí)(2016)[J].中華婦產(chǎn)科雜志,2016,51(8):561-564.
[41] 周利鍇,鄭文金.子宮肌瘤術(shù)后對(duì)分娩方式的影響研究[J].中國繼續(xù)醫(yī)學(xué)教育,2018,10(16):34-35.
[42] Chen L,Shi HF,Jiang H,et al.Correlation of an ultrasonic scoring system and intraoperative blood loss in placenta accreta spectrum disorders:a retrospective cohort study[J].Biomed Environ Sci,2021,34(2):163-169.
[43] 中華醫(yī)學(xué)會(huì)婦產(chǎn)科學(xué)分會(huì)產(chǎn)科學(xué)組.產(chǎn)后出血預(yù)防與處理指南(2014)[J].中華婦產(chǎn)科雜志,2014,49(9):641-646.
[44] Chen B,Zhang L,Wang D,et al.Nomogram to predict postpartum hemorrhage in cesarean delivery for women with scarred uterus:a retrospective cohort study in China[J].J Obstet Gynaecol Res,2020,46(9):1772-1782.
[45] 汪雪梅,繆小紅,勞瑋淑.瘢痕子宮產(chǎn)婦剖宮產(chǎn)術(shù)后感染現(xiàn)狀調(diào)查及影響因素[J].中國消毒學(xué)雜志,2020,37(3):233-235.
參考文獻(xiàn)滑動(dòng)預(yù)覽
聯(lián)系客服